Literature DB >> 18771496

What happens to new-onset headache presented to primary care? A case-cohort study using electronic primary care records.

D Kernick1, S Stapley, P J Goadsby, W Hamilton.   

Abstract

In the UK, 4% of general practitioner consultations are for headache, yet the natural history of these presentations is unknown. The objective of this study was to describe the outcome of new headache presentations to the general practitioner. This was a prospective case-control study in adults over a period of 1 year using data from the General Practitioner Research Database, UK. Records of patients who presented with primary headache (migraine, tension-type headache, cluster headache) or undifferentiated headache (no further descriptor) were examined for the subsequent year for subarachnoid haemorrhage, primary brain tumour, benign space-occupying lesion, temporal arteritis, stroke and transient ischaemic attack. We identified 21,758 primary headaches and 63,921 undifferentiated headaches. The likelihood ratio was 29 (9.9, 92) for a subarachnoid haemorrhage after an undifferentiated headache and increased with age. The 1-year risk of a malignant brain tumour with new undifferentiated headache was 0.15%, rising to 0.28% above the age of 50 years. For primary headache the risk was 0.045%. The risk for a benign space-occupying lesion was 0.05% for an undifferentiated and 0.009% for a primary headache. The risk of temporal arteritis was the highest of the conditions studied, 0.66% in the undifferentiated and 0.18% in the primary headache group. Accepting the limitations of this approach, our data can inform management guidelines for new presentations of headache in primary care and confirm the need for follow-up, even if a primary headache diagnosis is made.

Entities:  

Mesh:

Year:  2008        PMID: 18771496     DOI: 10.1111/j.1468-2982.2008.01674.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  15 in total

Review 1.  It IS a tumor -- current review of headache and brain tumor.

Authors:  Kevin Kahn; Alan Finkel
Journal:  Curr Pain Headache Rep       Date:  2014-06

2.  Should GPs have direct access to neuroradiological investigation when adults present with headache?

Authors:  David Kernick; Stuart Williams
Journal:  Br J Gen Pract       Date:  2011-06       Impact factor: 5.386

3.  Headache disorders: differentiating and managing the common subtypes.

Authors:  Fayyaz Ahmed
Journal:  Br J Pain       Date:  2012-08

4.  Headache: two views on the right approach in general practice.

Authors:  Timothy Taylor; Nikos Evangelou; Hugh Porter; William Hamilton; David Kernick
Journal:  Br J Gen Pract       Date:  2014-09       Impact factor: 5.386

Review 5.  Symptomatic diagnosis of cancer of the brain and central nervous system in primary care: a systematic review.

Authors:  Mia Schmidt-Hansen; Sabine Berendse; William Hamilton
Journal:  Fam Pract       Date:  2015-10-14       Impact factor: 2.267

Review 6.  What might the ideal electronic medical record for migraine headache look like?

Authors:  Michael J Marmura; Stephanie J Nahas
Journal:  Curr Pain Headache Rep       Date:  2010-06

Review 7.  The diagnosis and treatment of chronic migraine.

Authors:  Mark W Weatherall
Journal:  Ther Adv Chronic Dis       Date:  2015-05       Impact factor: 5.091

Review 8.  Assessment of acute headache in adults - what the general physician needs to know.

Authors:  Krishna Chinthapalli; Anne-Marie Logan; Rohit Raj; Niranjanan Nirmalananthan
Journal:  Clin Med (Lond)       Date:  2018-10       Impact factor: 2.659

9.  Imaging patients with suspected brain tumour: guidance for primary care.

Authors:  David P Kernick; Fayyaz Ahmed; Anish Bahra; Andrew Dowson; Giles Elrington; Manuela Fontebasso; Nicola J Giffin; Sue Lipscombe; Anne MacGregor; Richard Peatfield; Stuart Weatherby; Tom Whitmarsh; Peter J Goadsby
Journal:  Br J Gen Pract       Date:  2008-12       Impact factor: 5.386

10.  Prediagnostic symptoms and signs of adult glioma: the patients' view.

Authors:  Marthe C M Peeters; Linda Dirven; Johan A F Koekkoek; Ellen G Gortmaker; Lara Fritz; Maaike J Vos; Martin J B Taphoorn
Journal:  J Neurooncol       Date:  2020-01-01       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.